Survey: 560 Products Developed Since April; GSK And Chugai Top Anti-Cancer Drugs; Takeda Makes Breakthrough
This article was originally published in PharmAsia News
Among 560 new products developed by 64 pharmaceutical companies, anti-cancer drugs comprise one-third of the drugs.
You may also be interested in...
FDA seems poised to approve the drug for the orphan eye disease called TED, but remains concerned about labeling for some adverse events.
The apparently first-ever FDA press release for an advertising warning letter underscores importance of opioid issues – and the agency’s changing approach to media relations in general. FDA objects to Alkermes journal ad that excludes risk information about its opioid dependence treatment drug.